←
Sam Hall7,238 posts
Sam Hall avatar

Sam Hall

@samhall404

Raising awareness of psychiatric drug withdrawal. Sharing the reality, the science and fight for recognition. IG - samhall404

◷ Joined September 2012▧ 303 Photos and videos
Sam Hall avatar
Sam Hall@samhall404·Apr 30

1/ Thanks to @MikhailaFuller for allowing me to share my story. 🧵 My experience sits in the uncomfortable space between what patients are routinely told about antidepressants and what can, in many cases, actually unfold over time. It is not simply a story of adverse effects, it is a story about the consequences of incomplete information, overconfidence in simplified narratives and a medical culture that too often defaults to explanation rather than investigation when things go wrong. I was prescribed the antidepressant Sertraline for situational panic attacks following a house fire when I was younger and remained on it for approximately 13 years. During that time, I was never meaningfully informed about the possibility of physiological dependence, nor about the potential difficulty of stopping the drug after long term use. The phrase “safe and effective” was presented as if it were a stable, universal truth, rather than a context dependent conclusion drawn from limited and biased data. There was no discussion of what happens when the brain adapts to a drug over more than a decade. No acknowledgement that removing that drug might not be a neutral act. No mention of protracted withdrawal or that stopping could result in a severe and prolonged destabilisation of the nervous system. Informed consent, in any meaningful sense, was absent. When I eventually came off the SSRI, it was done through a rapid doctor led taper that bore no relation to the duration of my use. What followed was not a return of my original symptoms, but the onset of something far more severe, complex, disabling and life changing. Almost immediately, I began to experience intense and persistent surges of physiological anxiety and panic. These were not thoughts or worries in the conventional sense. They were full body events; overwhelming waves of adrenaline that arose without psychological trigger, accompanied by a profound sense of internal threat. They were not responsive to reasoning, reassurance or standard psychological strategies because they were not primarily psychological in origin. Alongside this, I developed widespread neurological and sensory disturbances. I experienced constant “electric” sensations throughout my body, moving unpredictably through my arms, legs, hands and across my head and face. These were often painful, presenting as burning, tingling or sharp nerve like sensations. My muscles began to twitch involuntarily, with fasciculations and spasms becoming a daily occurrence. At times, my facial muscles would contract and twitch without warning. One of the most severe and distressing symptoms I experienced was akathisia. It is often described clinically as restlessness, but that description is profoundly inadequate. What I experienced was an intense, unrelenting inner agitation combined with a powerful urge to escape my own body, alongside a compulsion to move that made stillness feel intolerable. At its worst, it generated intense suicidal urges, not from hopelessness, but from a desperate need to escape the sensation itself. It was not psychological distress in any conventional sense, it was a physical state that overrode any attempt at control. It is difficult to overstate how severe and destabilising this symptom has been for three years. Sleep became almost impossible at times. I went through prolonged periods of insomnia, sometimes sleeping only three hours across several days. When I did manage to fall asleep, I was frequently jolted awake by hypnic jerks; sudden, violent awakenings accompanied by adrenaline surges. The cumulative effect of this sleep deprivation was profound, amplifying every other symptom and eroding my ability to cope. Cognitively, I experienced significant impairment. I developed … prescribed-harm.com/stories/…

Sam Hall avatar
Sam Hall@samhall404·1h

*** ‼️ Just to add an important caveat: if you’re experiencing emotional blunting while taking antidepressants, please don’t rush to come off them. Speak to a medical professional who understands hyperbolic tapering and can help you plan a gradual, safe reduction. Do your research and seek appropriate support before making any changes to your dose.

Sam Hall avatar
Sam Hall@samhall404·1h

The feeling when you gradually hyperbolically taper your antidepressant and start rediscovering the world around you. Colours seem brighter, music takes on a whole new depth, nature becomes more fascinating and even the simplest things bring you joy. You find yourself experiencing moments of genuine awe at things you barely noticed before. It’s like slowly waking up from a trance you’ve been in for years, as the emotional numbness lifts and your brain gradually comes back online. You begin reconnecting with parts of yourself you thought you’d lost, feeling love, excitement, connection and the full range of human emotions again. It’s quite something, both exciting and terrifying, to realise just how much of the world you’ve been missing.

0:13
Alyne Duthie avatar
⟳ Sam Hall retweeted
Alyne Duthie@DuthieAlyne·3h

One man in his 60s described the effects of taking antidepressants as "suppressed love, joy, optimism, hope and creativity". "When he tried to stop taking his pills, he suffered distressing and prolonged withdrawal symptoms with little support from his GP."

Antidepressant prescriptions soar to record 9.1 million as MP warns of devastating side effects “Only 1 in 8 benefit while all users at risk of side effects” gbnews.com/health/antidepres…

Carrie Clark avatar
⟳ Sam Hall retweeted
Carrie Clark@cwestonclark·2h

"When You Can’t Win on the Science, Attack the Scientist - Jack Goulder, @joannamoncrieff and the politics of personality." Out now 👇

Post attachment
Michael Brazendale avatar
⟳ Sam Hall retweeted
Michael Brazendale@brazendale5·7h

"In 2026, surely the embarrassing position is psychiatry refusing to have a more honest and nuanced discussion about what ‘working’ actually means, who these drugs help, who they harm and what people are expected to sacrifice in the process."

“In 2026, to publicly doubt that antidepressants work at all is, frankly, embarrassing.” What exactly do you mean by ‘work’ in this context? That’s a rather important distinction. Do you mean they reduce scores on depression questionnaires, suppress certain emotional responses or make someone feel less distressed? Or do you mean they genuinely restore someone’s ability to experience happiness, love, connection, motivation and a fulfilling life? If someone takes an antidepressant and becomes so emotionally blunted that they struggle to feel love for their own family, lose their ability to experience joy from music, nature and relationships and feel disconnected from their own identity (arguably some of the most fundamental parts of being human) but simultaneously find themselves less emotionally affected by losing their job or experiencing personal hardship, would you consider that a successful outcome? We need to move beyond the simplistic argument that because a drug produces a measurable change in certain symptoms it must therefore be working in any meaningful sense. There’s a world of difference between a statistical improvement on a clinical rating scale and a genuine improvement in someone’s quality of life. We should also be asking how much benefit is attributable to the drug itself, how durable that benefit is, how many people experience little or no meaningful improvement and what adverse effects they’re expected to tolerate. In 2026, surely the embarrassing position is psychiatry refusing to have a more honest and nuanced discussion about what ‘working’ actually means, who these drugs help, who they harm and what people are expected to sacrifice in the process.

Carrie Clark avatar
⟳ Sam Hall retweeted
Carrie Clark@cwestonclark·8h

I’m glad Joanna has responded to Jack Goulder’s fact-free attack on her personality and politics. I have a short article coming out about this later today. Link to subscribe below 👇

Post attachment

My response to John Goulder's hit-piece against me & other critics of antidepressants. It presents itself as 'an account of a quaint, historical controversy..whereas it is actually a partisan intervention in a contemporary and ongoing debate.' joannamoncrieff.wordpress.co…

Sam Hall avatar
⟳ Sam Hall retweeted
Sam Hall@samhall404·20h

“In 2026, to publicly doubt that antidepressants work at all is, frankly, embarrassing.” What exactly do you mean by ‘work’ in this context? That’s a rather important distinction. Do you mean they reduce scores on depression questionnaires, suppress certain emotional responses or make someone feel less distressed? Or do you mean they genuinely restore someone’s ability to experience happiness, love, connection, motivation and a fulfilling life? If someone takes an antidepressant and becomes so emotionally blunted that they struggle to feel love for their own family, lose their ability to experience joy from music, nature and relationships and feel disconnected from their own identity (arguably some of the most fundamental parts of being human) but simultaneously find themselves less emotionally affected by losing their job or experiencing personal hardship, would you consider that a successful outcome? We need to move beyond the simplistic argument that because a drug produces a measurable change in certain symptoms it must therefore be working in any meaningful sense. There’s a world of difference between a statistical improvement on a clinical rating scale and a genuine improvement in someone’s quality of life. We should also be asking how much benefit is attributable to the drug itself, how durable that benefit is, how many people experience little or no meaningful improvement and what adverse effects they’re expected to tolerate. In 2026, surely the embarrassing position is psychiatry refusing to have a more honest and nuanced discussion about what ‘working’ actually means, who these drugs help, who they harm and what people are expected to sacrifice in the process.

Sam Hall avatar
⟳ Sam Hall retweeted
Sam Hall@samhall404·Nov 17

🧵 1/ Today I’ve started tapering from 3 mg of sertraline, having held this dose for over two years. I’m approaching four years of protracted withdrawal after being taken off 150 mg of sertraline following long term use. What followed was a succession of drug switches, high dose reinstatements with adverse reactions and dosage changes after my withdrawal symptoms were misdiagnosed as a mood disorder, FND and potentially bipolar disorder, amongst other things. Unfortunately, reinstating 3 mg of sertraline did nothing to stabilise my system. Despite remaining on this dose for over two years, I continue to experience significant neurological and physical symptoms. I’m now questioning, with the help of a knowledgable psychiatrist and clinic, whether continued exposure to sertraline could actually be contributing to or aggravating my symptoms, rather than providing any meaningful stabilisation. I also remain on 25 mg of quetiapine, originally prescribed to help with sleep during sertraline withdrawal, which may be contributing to some of the problems too. My main concern is the possibility of kindling and progressive nervous system sensitisation. Following repeated rapid tapers, reinstatements and switches between psychiatric drugs, my nervous system has become increasingly sensitive and reactive to pharmacological changes. Kindling is a term used to describe a process in which repeated episodes of stimulation or disruption can produce progressively greater responses to subsequent exposures. In the context of psychiatric drug withdrawal, the hypothesis is that repeated withdrawal episodes and drug changes may leave some individuals increasingly vulnerable to subsequent disruptions. The precise mechanisms in antidepressant withdrawal are not yet established and this remains an area requiring considerably more research. One possible explanation involves neuroadaptation. When someone takes an SSRI over an extended period, the brain adapts to the drug’s effects on serotonin signalling. Sertraline inhibits the serotonin transporter (SERT), reducing the reuptake of serotonin from the synaptic space. Over time, the nervous system makes compensatory adjustments to function in the presence of that ongoing pharmacological effect. When the drug is rapidly reduced or removed, those adaptations do not necessarily reverse at the same speed, potentially creating a period of physiological instability. There is also an important pharmacological reason why I cannot simply stop taking 3 mg of sertraline because it appears to be a very small dose. Research using PET and SPECT brain imaging has demonstrated that the relationship between antidepressant dose and serotonin transporter occupancy is hyperbolic rather than linear. In other words, occupancy increases rapidly at lower doses before gradually approaching a plateau at higher therapeutic doses. A model based estimate published using this research suggests that approximately 2.2 mg of sertraline may produce around 20% SERT occupancy, while 5.9 mg may produce around 40%. This would put my 3 mg dose somewhere in the region of 20 - 25%, although this is an extrapolation rather than a direct measurement at my dose. This is significant because 3 mg is not necessarily pharmacologically insignificant. Even at this low dose, sertraline may still be occupying a meaningful proportion of serotonin transporters. Reducing it too quickly could therefore produce further pharmacological changes that my already sensitive system may struggle to accommodate. My symptoms currently include bouts of akathisia, muscles in my legs tightening and cramping as though locked in a vice, intense head pressure and electrical sensations throughout my body, almost as though electrical cables have been severed, alongside numerous other neurological and sensory disturbances. I’m concerned that these symptoms may be related to previous withdrawal, ongoing drug exposure or a combination of both. I don’t …

Post attachment
Jenn avatar
⟳ Sam Hall retweeted
Jenn@GhostGirl1317·16h

For a decade and a half straight, I had my emotional connections to this world stolen. For all intents and purposes, I was a dead woman walking. I want the happiness, sadness, pain, celebration, and even the agony of my 20s (and half my 30s) back. That wasn't informed consent.

“In 2026, to publicly doubt that antidepressants work at all is, frankly, embarrassing.” What exactly do you mean by ‘work’ in this context? That’s a rather important distinction. Do you mean they reduce scores on depression questionnaires, suppress certain emotional responses or make someone feel less distressed? Or do you mean they genuinely restore someone’s ability to experience happiness, love, connection, motivation and a fulfilling life? If someone takes an antidepressant and becomes so emotionally blunted that they struggle to feel love for their own family, lose their ability to experience joy from music, nature and relationships and feel disconnected from their own identity (arguably some of the most fundamental parts of being human) but simultaneously find themselves less emotionally affected by losing their job or experiencing personal hardship, would you consider that a successful outcome? We need to move beyond the simplistic argument that because a drug produces a measurable change in certain symptoms it must therefore be working in any meaningful sense. There’s a world of difference between a statistical improvement on a clinical rating scale and a genuine improvement in someone’s quality of life. We should also be asking how much benefit is attributable to the drug itself, how durable that benefit is, how many people experience little or no meaningful improvement and what adverse effects they’re expected to tolerate. In 2026, surely the embarrassing position is psychiatry refusing to have a more honest and nuanced discussion about what ‘working’ actually means, who these drugs help, who they harm and what people are expected to sacrifice in the process.

Bert avatar
⟳ Sam Hall retweeted
Bert@HenryRunamucker·17h

If a drug very marginally reduces short-term symptoms, but increases suicide risk and all-cause mortality, does that mean it "works"?

“In 2026, to publicly doubt that antidepressants work at all is, frankly, embarrassing.” What exactly do you mean by ‘work’ in this context? That’s a rather important distinction. Do you mean they reduce scores on depression questionnaires, suppress certain emotional responses or make someone feel less distressed? Or do you mean they genuinely restore someone’s ability to experience happiness, love, connection, motivation and a fulfilling life? If someone takes an antidepressant and becomes so emotionally blunted that they struggle to feel love for their own family, lose their ability to experience joy from music, nature and relationships and feel disconnected from their own identity (arguably some of the most fundamental parts of being human) but simultaneously find themselves less emotionally affected by losing their job or experiencing personal hardship, would you consider that a successful outcome? We need to move beyond the simplistic argument that because a drug produces a measurable change in certain symptoms it must therefore be working in any meaningful sense. There’s a world of difference between a statistical improvement on a clinical rating scale and a genuine improvement in someone’s quality of life. We should also be asking how much benefit is attributable to the drug itself, how durable that benefit is, how many people experience little or no meaningful improvement and what adverse effects they’re expected to tolerate. In 2026, surely the embarrassing position is psychiatry refusing to have a more honest and nuanced discussion about what ‘working’ actually means, who these drugs help, who they harm and what people are expected to sacrifice in the process.

Psychotropic Deprescribing Council avatar
⟳ Sam Hall retweeted
Psychotropic Deprescribing Council@PsychotropicDC·Nov 17

People who are suffering protracted withdrawal syndrome from psychiatric drugs are in a similar situation. No amount of CBT will make the withdrawal symptoms go away. What psychotherapy might be able to do is foster coping skills while recovery slowly occurs.

🚨 Finally, after a lot of back-and-forth, my paper on why psychotherapies SHOULD NOT be used as standard treatment for #POTS, is published! Key points: 🧠 There is NO scientific evidence that mind-body, CBT, neuroplasticity, etc. therapies are effective for treatment of POTS symptoms. 🧠 Promoting psychotherapies without evidence-based data inadvertently creates further barriers to patient care (see figure below). 🧠 This paper does not argue against psychotherapies, psychologists or psychiatrists: it argues to implement these therapies for patients who truly need them: those with comorbid mood disorders, psychological issues, poor coping mechanisms, medical trauma, etc - not "everyone with POTS." Clinical observation: Patients with POTS are commonly treated with antidepressants and psychotherapies, but my 2 papers highlight that there is NO scientific evidence that either of those treatments work for POTS. Clinical practice: Clinicians should use standard therapies (salt, fluids, beta blockers, midodrine, ivabradine, etc) to treat POTS. Antidepressants and psychotherapies are NOT standard therapies. frontiersin.org/journals/neu…

Post attachment
Dr Joanna Moncrieff avatar
⟳ Sam Hall retweeted
Dr Joanna Moncrieff@joannamoncrieff·Nov 17

My response to John Goulder's hit-piece against me & other critics of antidepressants. It presents itself as 'an account of a quaint, historical controversy..whereas it is actually a partisan intervention in a contemporary and ongoing debate.' joannamoncrieff.wordpress.co…

Medicating Normal avatar
⟳ Sam Hall retweeted
Medicating Normal@MedicatingNorm1·Nov 17

"Is it withdrawal or relapse?" Author: Laura Farach, MD, FAAP KEY TAKEAWAYS: -" Fluoxetine is not 'self-tapering': withdrawal can occur despite its long half-life, and onset may be delayed weeks to months after discontinuation. - New, unfamiliar, or unusually intense emotional symptoms accompanied by physical or sensory symptoms after discontinuation point toward withdrawal rather than relapse. - Long-term treatment and irregular adherence raise withdrawal risk, and mistaking withdrawal for relapse can lead to unnecessary medication exposure." buff.ly/LxFQnJi